About us

Hybio Pharmaceutical (Hubei) Wuhan subsidiary is a national high-tech enterprise specializing in the research, production and marketing of peptide characteristic APIs, a specialized and special new small and medium-sized enterprise in Hubei Province, a green factory in Hubei Province, and a health enterprise in Hubei Province. The company is located in the Airport Demonstration Industrial Park in Huangpi District, Wuhan City, designed and built in accordance with international cGMP standards, introducing international leading production technology and advanced equipment, and a world-class biomedical production base. With advanced automatic peptide synthesis system, automatic purification system and advanced facilities and equipment, with a complete GMP management system and professional and technical personnel, the peptide API production base has passed the official GMP certification of China/the United States/Australia and other countries.

• International standard certification

  Meets cGMP, EU-GMP, FDA-GMP requirements

• Large-scale capacity expansion

  It is expanding its API production line and is committed to building a world-class peptide API and biomedical production base

• Intelligent production system

  Equipped with fully automated synthesis/purification systems and state-of-the-art facilities

Relying on the relevant industrial policies of Yunnan Province and Dali Prefecture, Hybio Pharmaceutical (Yunnan) Dali Subsidiary focuses on the development of four major business segments, with industrial hemp products and medical institution preparations as the main development business, and pharmaceutical culture media, nicotine and natural plant extracts as auxiliary business segments. The company has the advantages of GMP management standards of pharmaceutical enterprises, and can quickly cut into the research and development and production of traditional Chinese medicine preparations, industrial hemp drugs, and natural plant extracts for health products, forming a comparative advantage in the industrial chain - in the purification and processing of industrial hemp CBD, traditional Chinese medicine preparations, and natural plant extracts, it has process design technical capabilities, and can fully support drug research and development, production, patent application, registration, efficacy evaluation and other technical links, and quickly realize the industrialization ability of products. It can purify CBD crystals + CBD full-spectrum oil at the same time, as well as the compatibility of traditional Chinese medicine preparations and natural plant extracts as raw materials and other processes, which is conducive to the development of diversified products.

• Dual-core drive

  Industrial hemp products, preparations for medical institutions

• Characteristic process technology

  CBD purification (crystals + full-spectrum oil), traditional Chinese medicine preparations and plant extract processing

• GMP empowerment

  Pharmaceutical standards ensure compliant and efficient production

Hybio Pharmaceutical (Gansu) Chengji Subsidiary is a large-scale high-tech modern comprehensive enterprise integrating R&D, production and sales of drugs and medical devices. It is one of the few dual-certificate enterprises in China with "Drug Production License" and "Medical Device Production License". The company covers an area of 117 acres and has a registered capital of 229 million yuan. The company has 170 drug registration approvals, including lyophilized powder injections, small-volume injections, tablets, capsules, granules, syrups, powders, oral liquids, APIs, large-capacity injections, etc. The company has 15 medical device registration certificates and 105 patented technologies.

• Floor area

  117 acres

• Drug registration approval

  170

• Patented technology

  105 items

As a preparation production base, Hybio Pharmaceutical (Shenzhen) Pingshan Branch covers an area of 25,000 square meters and is listed as a "major construction project for industrial revitalization" by the National Development and Reform Commission. It is built with full reference to European and American cGMP standards, and has production lines representing the international advanced level, including 3 vial production lines, 1 cartridge production line and 1 pre-potting production line. Since it started production in 2013, it has successfully obtained GMP certificates from the following regulatory agencies: China NMPA, US FDA, EU EMA, Brazil ANVISA, Pakistan MOH, Indonesia BPOM, etc.

• Floor area

  25,000 square meters

• International advanced production line

  vial production line, cartridge production line, pre-filling production line, etc

• International GMP certification

  China NMPA, US FDA, EU EMA, Brazil ANVISA, Pakistan MOH, Indonesia BPOM, etc